$2.61 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 93 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 39.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON PHARMA PLC | $170,807,000 | +28.1% | 6,462,634 | -5.3% | 6.55% | +22.7% |
| XENT | Sell | INTERSECT ENT INC | $64,492,000 | +10.1% | 2,005,964 | -3.5% | 2.47% | +5.5% |
| XLRN | Sell | ACCELERON PHARMA INC | $58,453,000 | -3.2% | 1,255,174 | -9.5% | 2.24% | -7.3% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $53,216,000 | -4.6% | 6,537,566 | -5.4% | 2.04% | -8.6% |
| ARGX | Sell | ARGENX SEsponsored adr | $49,156,000 | +8.4% | 393,750 | -16.6% | 1.88% | +3.9% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $40,575,000 | +44.5% | 506,865 | -2.7% | 1.56% | +38.4% |
| NVRO | Sell | NEVRO CORP | $36,222,000 | +1.9% | 579,463 | -36.6% | 1.39% | -2.4% |
| VCEL | Sell | VERICEL CORP | $29,574,000 | -54.4% | 1,689,000 | -54.7% | 1.13% | -56.3% |
| EHTH | Sell | EHEALTH INC | $27,405,000 | -33.7% | 439,609 | -59.2% | 1.05% | -36.5% |
| Sell | DEXCOM INCnote 0.750% 5/1 | $26,865,000 | -63.6% | 20,000,000 | -63.6% | 1.03% | -65.1% | |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $23,646,000 | -44.3% | 2,355,136 | -5.7% | 0.91% | -46.6% |
| Sell | WRIGHT MED GROUP N Vnote 2.250%11/1 | $21,065,000 | -34.6% | 13,625,000 | -42.3% | 0.81% | -37.3% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $20,842,000 | -21.2% | 176,958 | -38.6% | 0.80% | -24.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $18,486,000 | -50.2% | 252,200 | -71.2% | 0.71% | -52.3% |
| GKOS | Sell | GLAUKOS CORP | $17,850,000 | -36.9% | 227,762 | -54.8% | 0.68% | -39.6% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $16,972,000 | -46.4% | 144,194 | -71.5% | 0.65% | -48.6% |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $15,919,000 | -58.9% | 119,000 | -64.2% | 0.61% | -60.6% |
| ANTM | Sell | ANTHEM INC | $15,210,000 | -39.0% | 53,000 | -44.2% | 0.58% | -41.6% |
| MOH | Sell | MOLINA HEALTHCARE INC | $12,209,000 | -30.8% | 86,000 | -43.3% | 0.47% | -33.7% |
| NVTA | Sell | INVITAE CORP | $9,677,000 | +27.2% | 413,200 | -39.9% | 0.37% | +21.6% |
| INSP | Sell | INSPIRE MED SYS INC | $7,892,000 | -53.4% | 139,000 | -65.3% | 0.30% | -55.3% |
| PFNX | Sell | PFENEX INC | $5,674,000 | +66.3% | 918,187 | -14.1% | 0.22% | +59.1% |
| AXGT | Sell | AXOVANT SCIENCES LTD | $5,281,000 | -47.0% | 3,970,326 | -60.3% | 0.20% | -49.1% |
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $3,434,000 | +34.7% | 253,400 | -60.1% | 0.13% | +29.4% |
| OSMT | Sell | OSMOTICA PHARMACEUTICALS PLC | $3,046,000 | -65.5% | 846,048 | -25.7% | 0.12% | -66.9% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $2,254,000 | -89.3% | 35,500 | -93.6% | 0.09% | -89.8% |
| Sell | IGI LABORATORIES INCnote 3.750%12/1 | $1,688,000 | -53.5% | 1,733,000 | -53.6% | 0.06% | -55.2% | |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $1,415,000 | -30.4% | 32,000 | -45.1% | 0.05% | -33.3% |
| HSGX | Exit | HISTOGENICS CORP | $0 | – | -296,099 | -100.0% | -0.00% | – |
| MLNT | Exit | MELINTA THERAPEUTICS INC | $0 | – | -333,902 | -100.0% | -0.01% | – |
| RMED | Exit | RA MED SYS INC | $0 | – | -108,400 | -100.0% | -0.04% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -943,298 | -100.0% | -0.04% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -117,647 | -100.0% | -0.04% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS IN | $0 | – | -419,000 | -100.0% | -0.05% | – |
| NVTRQ | Exit | NUVECTRA CORP | $0 | – | -129,000 | -100.0% | -0.08% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -767,000 | -100.0% | -0.11% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -475,000 | -100.0% | -0.18% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -71,500 | -100.0% | -0.26% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -235,576 | -100.0% | -0.31% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -129,000 | -100.0% | -0.33% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -622,548 | -100.0% | -0.38% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -1,343,181 | -100.0% | -0.42% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -109,117 | -100.0% | -0.42% | – |
| ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -621,000 | -100.0% | -0.64% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -180,000 | -100.0% | -0.96% | – |
| CVS | Exit | CVS HEALTH CORPcall | $0 | – | -566,800 | -100.0% | -1.49% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.